advertisement
11.14 Investigational drugs; pharmacological experiments (92)
Showing records 1 to 25
Display all abstracts in classification 11.14 Investigational drugs; pharmacological experiments
Search within classification 11.14 Investigational drugs; pharmacological experiments66236 Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy
Acharya S
Bioorganic and Medicinal Chemistry Letters 2016; 26: 1490-1494
66506 Neuroprotective effect of lignans extracted from Eucommia ulmoides Oliv. on glaucoma-related neurodegeneration
Li CP
Neurological Sciences 2016; 37: 755-762
66220 The Endocannabinoid System as a Therapeutic Target in Glaucoma
Cairns EA
Neural plasticity 2016; 2016: 9364091
65857 Cytidine 5'-Diphosphocholine (Citicoline) in Glaucoma: Rationale of Its Use, Current Evidence and Future Perspectives
Roberti G
International journal of molecular sciences 2015; 16: 28401-28417
65820 Rho kinase inhibitors for glaucoma treatment - Review
Germano RA
Arquivos Brasileiros de Oftalmologia 2015; 78: 388-391
66257 Inhibition by a retinoic acid receptor γ agonist of extracellular matrix remodeling mediated by human Tenon fibroblasts
Liu Y
Molecular Vision 2015; 21: 1368-1377
65828 Palmitoylethanolamide, a Natural Retinoprotectant: Its Putative Relevance for the Treatment of Glaucoma and Diabetic Retinopathy
Keppel Hesselink JM
Journal of Ophthalmology 2015; 2015: 430596
65985 Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
Roy Chowdhury U
PLoS ONE 2015; 10: e0141783
65800 A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
Suto F
Investigative Ophthalmology and Visual Science 2015; 56: 7963-7970
66508 The Ocular Hypotensive Efficacy of Topical Fasudil, a Rho-Associated Protein Kinase Inhibitor, in Patients With End-Stage Glaucoma
Pakravan M
American Journal of Therapeutics 2017; 24: e676-e680
65831 New drugs and preparations for open-angle glaucoma in adults
Drug and therapeutics bulletin 2015; 53: 141-144
65815 Selective A2A receptor antagonist prevents microglia-mediated neuroinflammation and protects retinal ganglion cells from high intraocular pressure-induced transient ischemic injury
Madeira MH
Translational research : the journal of laboratory and clinical medicine 2016; 169: 112-128
66557 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells
Kaneko Y
Scientific reports 2016; 6: 19640
65926 Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease
Cairns EA
Journal of basic and clinical physiology and pharmacology 2016; 27: 253-265
65953 Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-(2S)-2-Aminopropyl-8,9-dihydro-7H-pyrano2,3-gindazol-8-ol a Selective 5-HT2 Receptor Agonist
May JA
Journal of Medicinal Chemistry 2015; 58: 8818-8833
66221 Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
Kokona D
Neural plasticity 2016; 2016: 8373020
66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Yin S
International Journal of Ophthalmology 2015; 8: 1101-1106
66236 Design and synthesis of novel hybrid sydnonimine and prodrug useful for glaucomatous optic neuropathy
Rogers P
Bioorganic and Medicinal Chemistry Letters 2016; 26: 1490-1494
65985 Ocular Hypotensive Effects of the ATP-Sensitive Potassium Channel Opener Cromakalim in Human and Murine Experimental Model Systems
Bahler CK
PLoS ONE 2015; 10: e0141783
65953 Ocular Hypotensive Response in Nonhuman Primates of (8R)-1-(2S)-2-Aminopropyl-8,9-dihydro-7H-pyrano2,3-gindazol-8-ol a Selective 5-HT2 Receptor Agonist
Sharif NA
Journal of Medicinal Chemistry 2015; 58: 8818-8833
65800 A Novel Dual Agonist of EP3 and FP Receptors for OAG and OHT: Safety, Pharmacokinetics, and Pharmacodynamics of ONO-9054 in Healthy Volunteers
Rowe-Rendleman CL
Investigative Ophthalmology and Visual Science 2015; 56: 7963-7970
66338 Extraction (DSX) from Erigeron breviscapus modulates outward potassium currents in rat retinal ganglion cells
Wang ZF
International Journal of Ophthalmology 2015; 8: 1101-1106
66557 Effects of K-115 (Ripasudil), a novel ROCK inhibitor, on trabecular meshwork and Schlemm's canal endothelial cells
Ohta M
Scientific reports 2016; 6: 19640
65926 Seeing over the horizon - targeting the endocannabinoid system for the treatment of ocular disease
Toguri JT
Journal of basic and clinical physiology and pharmacology 2016; 27: 253-265
66221 Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease
Georgiou PC
Neural plasticity 2016; 2016: 8373020
